Results 111 to 120 of about 114,221,800 (220)

Influenza virus activation of the interferon system [PDF]

open access: yes, 2015
This study was supported by the Wellcome Trust (grant number 087751/A/08/Z) and the Medical Research Council (grant number G0700848).The host interferon (IFN) response represents one of the first barriers that influenza viruses must surmount in order to ...
Fodor, Ervin   +8 more
core   +1 more source

Phylogenetic and molecular characteristics of Eurasian H9 avian influenza viruses and their detection by two different H9-specific RealTime reverse transcriptase polymerase chain reaction tests [PDF]

open access: yes, 2013
Avian influenza viruses (AIVs) of the H9 haemagglutinin subtype are endemic in many Asian and Middle-East countries, causing mortality and morbidity in poultry.
Krill, D.   +9 more
core   +1 more source

Strategy to Enhance Influenza Surveillance Worldwide

open access: yesEmerging Infectious Diseases, 2009
The emergence of a novel strain of influenza virus A (H1N1) in April 2009 focused attention on influenza surveillance capabilities worldwide. In consultations before the 2009 outbreak of influenza subtype H1N1, the World Health Organization had concluded
Justin R. Ortiz   +7 more
doaj   +1 more source

THREAT OF SWINE FLU OUTBREAK

open access: yesGomal Journal of Medical Sciences, 2015
Influenza A (H1N1) virus is responsible for swine flu. It can easily cross the species barrier and zoonotic jumps from pigs to humans have been observed. It emerged from Mexico in 2009 and spread with travelers worldwide, resulting in swine flu pandemic.
Iftikhar Ahmad, Habibullah Khan
doaj  

A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus

open access: yesVirology Journal, 2010
Background Highly pathogenic avian influenza virus subtype H5N1 infects humans with a high fatality rate and has pandemic potential. Vaccination is the preferred approach for prevention of H5N1 infection.
Chang Haiyan   +6 more
doaj   +1 more source

Emergence and Fixing of Antiviral Resistance in Influenza A Via Recombination and Hitch Hiking [PDF]

open access: yes, 2009
The dramatic rise of oseltamivir resistance in the H1N1 serotype in the 2007/2008 season and the fixing of H274Y in the 2008/2009 season has raised concerns regarding individuals at risk for seasonal influenza, as well as development of similar ...
Henry L. Niman
core  

Novel influenza A (H1N1) virus–induced hemophagocytosis: first case reported in Saudi Arabia

open access: yesAnnals of Saudi Medicine, 2012
H1N1 is a novel subtype of the influenza A virus. Since its reemergence in 2008, it has been reported to cause a variety of illnesses ranging from mild flu-like symptoms to severe multiorgan failure.
Jalil Ur Rehman   +5 more
doaj   +1 more source

Estimating the impact of influenza vaccination and antigenic drift on influenza-related morbidity and mortality in England & Wales using hidden Markov models [PDF]

open access: yes
Influenza causes substantial morbidity and mortality in some influenza sea- sons, especially among the elderly. Influenza seasons dominated by circula- tion of influenza A/H3N2 virus tend to result in more morbidity and mor- tality than seasons ...
Mann, Andrea Gail
core   +1 more source

Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) disease [PDF]

open access: yes, 2011
In this group of patients hospitalized with pandemic influenza, a significant beneficial effect of pre-admission statin use on the in-hospital course of illness was not identified.
Brett, Stephen J.   +45 more
core   +1 more source

Comparative serological assays for the study of H5 and H7 avian influenza viruses. [PDF]

open access: yes, 2013
The nature of influenza virus to randomly mutate and evolve into new types is an important challenge in the control of influenza infection. It is necessary to monitor virus evolution for a better understanding of the pandemic risk posed by certain ...
Temperton, Nigel J.   +4 more
core  

Home - About - Disclaimer - Privacy